Genentech, Inc.
Phone: +16502251000
Fax: +1 (650) 225-6000
E-mail: https://www.gene.com/contact-us/email-us
| Type | Private ( Independent subsidiary) |
|---|---|
| Industry | Biotechnology |
| Founded | 1976 (1976) |
| Headquarters | South San Francisco, California, United States |
| Key people |
|
| Products | Avastin, Herceptin, Rituxan, Perjeta, Kadcyla, Gazyva, Tarceva, Ocrevus, Polivy, Tecentriq, Xofluza, Hemlibra, Venclexta, Esbriet, Cotellic, Alecensa, Zelboraf, Nutropin, Actemra, Lucentis, Xolair, Activase, Cathflo Activase, Xeloda, Boniva, TNKase, CellCept, Pegasys, Pulmozyme, Tamiflu, Valcyte, Anaprox, Cytovene, EC-Naprosyn, Erivedge, Fuzeon, Invirase, Klonopin, Kytril, Naprosyn, Rocephin, Roferon-A, Romazicon, Valium, Xenical, Zenapax |
| Revenue |  26.4 billion (2020) |
| Number of employees | 13,539 (July 2021) |
| Parent | Hoffmann-La Roche |
| Website | www.gene.com |
Genentech, Inc., is an American biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.
As of July 2021, Genentech employed 13,539 people.
For detailed contact information visit location pages below.
Genentech, Inc.'s locations around the world
North America
Clinical Trials sponsored by Genentech, Inc.
-
Genentech, Inc.Reclutamento
-
Genentech, Inc.ReclutamentoCarcinoma epatocellulareStati Uniti, Porto Rico
-
Genentech, Inc.ReclutamentoMieloma multiplo recidivato o refrattarioAustralia, Israele, Corea del Sud
-
Genentech, Inc.ReclutamentoMelanoma | Cancro cervicale | HCC | Tumore gastrico | Cancro colorettale | Cancro esofageo | NSCLC | Carcinoma uroteliale | HNSCC | Tumori solidi localmente avanzati o metastatici | TNBC | Clear Cell RCCOlanda, Spagna, Taiwan, Stati Uniti, Australia, Canada, Belgio, Svezia, Grecia, Corea del Sud
-
Genentech, Inc.Completato
-
Genentech, Inc.Attivo, non reclutanteRecettore degli estrogeni (ER)-positivo, HER2-negativo, carcinoma mammario localmente avanzato o metastaticoStati Uniti, Spagna, Giappone, Regno Unito, Germania, Taiwan, Argentina, Italia, Singapore, Grecia, Sud Africa, Corea del Sud, Turchia (Türkiye)
-
Genentech, Inc.A disposizioneCancro al seno ER+/HER2- in fase precoce o localmente avanzato/metastatico
-
Genentech, Inc.Attivo, non reclutanteEdema maculare diabeticoStati Uniti, Porto Rico
-
Genentech, Inc.Attivo, non reclutanteCancro colorettale | Carcinoma polmonare non a piccole cellule | Tumori solidi avanzatiNuova Zelanda, Canada, Spagna, Brasile, Belgio, Australia, Stati Uniti, Regno Unito, Israele, Olanda, Norvegia, Svizzera, Italia, Ungheria, Corea del Sud, Polonia, Kenya
-
Genentech, Inc.Attivo, non reclutanteEdema maculare diabeticoStati Uniti, India, Porto Rico, Kenya